CDTX - Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09 revenue of $6.22M beats by $0.01M August, 09 2022 05:25 PM Cidara Therapeutics Inc. Cidara Therapeutics press release ( NASDAQ: CDTX ): Q2 GAAP EPS of -$0.19 beats by $0.09 . Revenue of $6.22M (-81.1% Y/Y) beats by $0.01M . For further details see: Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09, revenue of $6.22M beats by $0.01M